Attached files

file filename
S-1/A - AMENDMWNT NO. 1 TO FORM S-1 - EKSO BIONICS HOLDINGS, INC.g6041.txt
EX-10.2 - VERBAL AGREEMENT - EKSO BIONICS HOLDINGS, INC.ex10-2.txt
EX-23.2 - CONSENT OF AUDITOR - EKSO BIONICS HOLDINGS, INC.ex23-2.txt

                                                                     Exhibit 5.1

Stepp Law Corporation
15707 Rockfield Blvd.
Suite 101
Irvine, California 92618
949.660.9700

May 29, 2012

PN Med Group Inc.
San Isidro, Depot 618
Santiago, Chile 8240400

Attention: Pedro Perez Niklitschek

     Re: Registration Statement on Form S-1

Dear Mr. Niklitschek:

As special counsel to PN Med Group Inc., a Nevada  corporation  (the "Company"),
we have been requested to provide our opinion regarding  5,000,000 shares of the
Company's  $.001 par value common stock to be registered for sale by the Company
pursuant to the provisions of that certain  registration  statement on Form S-1,
which is anticipated to be filed by the Company with the Securities and Exchange
Commission   (the   "SEC")   (the   "Registration   Statement")(the   "Shares").
Accordingly,  the  purpose of this letter is to  respond,  in  writing,  to that
request and  furnish  that  opinion.  The  opinion  specified  in this letter is
limited to Nevada law.

For purposes of  providing  the opinion  specified in this letter,  we have made
such legal and factual  examinations and inquiries,  including an examination of
photocopies, identified to our satisfaction being true copies of various records
of the Company,  including the Registration  Statement and such other documents,
instruments, corporate records and public records as we have deemed necessary or
appropriate.  Also,  we have  obtained  from  officers of the Company and relied
upon, such certificates,  representations and assurances as we deem necessary or
appropriate for the purposes of providing that opinion.

Without limiting the generality of the foregoing, we have, with your permission,
assumed without independent  verification that (i) each natural person executing
a document has sufficient legal capacity to do so; (ii) all documents  submitted
to us as originals are  authentic,  the signatures on all documents that we have
examined  are  genuine  and  all  documents  submitted  to  us  as  photocopies,
electronic or facsimile copies conform to the original  document;  and (iii) all
records  made  available  to us by the  Company  and all public  records we have
reviewed are accurate and complete.

Based  upon  the  foregoing  and  in  reliance  thereon,   and  subject  to  the
qualifications,  limitations,  exceptions  and  assumptions  specified  in  this
letter,  it is our  opinion  that the  Shares  (i) have  been  duly and  validly
authorized  for  issuance  and (ii) when  issued  pursuant  to the  Registration
Statement, will be validly issued, fully paid, and non-assessable.

PN Med Group Inc. May 29, 2012 Page 2 We confirm that we furnish no opinion with respect to the truth and accuracy or the completeness of the Registration Statement. The opinion specified in this letter is expressly limited to the matters specified in this letter, and we furnish no opinion, express or implied, as to any other matter relating to the Company or its securities. Accordingly, no provision of this letter is intended to, nor shall any such provision, be construed as an opinion concerning any matter not specified in this letter. The opinion specified in this letter is as of the date of this letter, and we assume no obligation to update or supplement that opinion, if any applicable law changes after the date of this letter or if we become aware after the date of this letter of any fact, whether existing before or occurring after the date of this letter, that might change the opinion specified in this letter. We consent to the (i) use of this letter as an exhibit to the Registration Statement, (ii) disclosure in the prospectus portion of the Registration Statement of the opinion specified in this letter, and (iii) use of our name in the Registration Statement in connection with that opinion. In giving the foregoing consent, we do not hereby admit that we are in the category of persons whose consent is required pursuant to Section 7 of the Securities Act of 1933, or the rules and regulations of the SEC. The Company is hereby advised, urged, and encouraged to consult with and, if appropriate, retain securities counsel in each jurisdiction outside the United States in which the Shares may be offered and sold regarding compliance with the securities laws of such jurisdiction. Finally, of course, in the event that you have questions or comments regarding this matter, please do not hesitate to contact us. Thank you. Sincerely, STEPP LAW CORPORATION /s/ Thomas E. Stepp, Jr. --------------------------------- By: Thomas E. Stepp, Jr